JW Shinyak Rises for Second Straight Day on Expectations of Expanded National Health Insurance Coverage for Hair-Loss Treatments

[Financial News] JW Shinyak is surging for a second straight day. Buying has been concentrated in related stocks as expectations for expanded National Health Insurance coverage of hair-loss treatments coincide with forecasts for growth in the global hair-loss treatment market.
As of 9:49 a.m. on the 2nd, JW Shinyak was trading at 3,275 won, up 9.53% from the previous trading day. It rose as high as 3,470 won early in the session, marking a gain of 16.05%. Trading volume had already surpassed 29 million shares, signaling strong buying interest.
JW Shinyak also rose 30% the previous day, closing at the daily price limit. At the time, news that hair-loss treatments were drawing attention in global markets as the next major growth sector after obesity treatments was also cited as a factor behind the strength of related stocks.
The market is paying particular attention to the possibility of expanded National Health Insurance coverage for hair-loss treatments. Related stocks previously attracted buying interest after the government said it would review plans to expand such coverage in the second half of this year.
However, some analysts say the current share-price rise partly reflects policy expectations being priced in ahead of time, as whether the coverage will actually be applied and its scope have not been finalized.
Meanwhile, JW Shinyak is classified as a stock related to hair-loss treatments because it has products in the finasteride class used to treat male-pattern hair loss. In addition to hair-loss treatments, the company also operates product lines for hair and scalp care.
[email protected] Kang Jung-mo Reporter